SEPTInvestingStart Free

BCAX SCHEDULE 13G/A: SEC filing

An institutional holder

Filed with the SEC on · accession 0001274173-26-000198

BCAX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 13, 2026. An institutional holder filed an amended Schedule 13G for Bicara Therapeutics Inc. (BCAX), indicating a change in beneficial ownership position. The stock moved -4.1% by the first close after the filing.

Summary of the filing

An institutional holder filed an amended Schedule 13G for Bicara Therapeutics Inc. (BCAX), indicating a change in beneficial ownership position. The filing includes a power of attorney and Item 7 disclosure but no specific ownership percentages are provided in the available text.

For details, click here →

Key details

IssuerBicara Therapeutics Inc.

How BCAX stock reacted

Close before

$24.63

Aug 12, 2026

First close after

-4.06%

$23.63

5 trading days

+4.99%

$25.86

Since filing

-64.88%

$8.65

✦ Ask GOAX AI about this filing — what it means for BCAX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for BCAX?

Click here

Frequently asked questions

What did BCAX file with the SEC on Aug 13, 2026?

BCAX filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G for Bicara Therapeutics Inc. (BCAX), indicating a change in beneficial ownership position. The filing includes a power of attorney and Item 7 disclosure but no specific ownership percentages are provided in the available text.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did BCAX stock react to this filing?

BCAX closed at $24.63 before the filing and $23.63 on Aug 13, 2026 (-4.06%). Five trading days later: $25.86 (+4.99%).

Other BCAX SEC filings

Get alerts when BCAX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
BCAX overviewBCAX analysisBCAX newsLatest SEC filings